APA (7th ed.) Citation

Dai, J., Xu, T., Li, L., Fang, M., Lin, J., Cao, J., . . . Si, L. (2025). Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma. Clinical and Translational Medicine, 15(1), . https://doi.org/10.1002/ctm2.70169

Chicago Style (17th ed.) Citation

Dai, Jie, et al. "Atezolizumab Plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma." Clinical and Translational Medicine 15, no. 1 (2025). https://doi.org/10.1002/ctm2.70169.

MLA (9th ed.) Citation

Dai, Jie, et al. "Atezolizumab Plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma." Clinical and Translational Medicine, vol. 15, no. 1, 2025, https://doi.org/10.1002/ctm2.70169.